Professor, Neurosurgery, University of Utah School of Medicine
Neurosurgery
Dr. Randy L. Jensen, MD
|
|
Give Review
Randy Jensen practices Neurosurgery. He studied medicine at University of Utah School of Medicine. He received awards:"Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification", "Fellow (FACS)" and "Fellow (FAANS)". Randy Jensen is also published. He has 61 publications published. The lastest publication: "Combined Hydroxyurea and Verapamil in the Clinical Treatment of Refractory Meningioma: Human and Orthotopic Xenograft Studies.'
Publications
- Combined Hydroxyurea and Verapamil in the Clinical Treatment of Refractory Meningioma: Human and Orthotopic Xenograft Studies.
- Navigated transcranial magnetic stimulation: another tool for preoperative planning for patients with motor-eloquent Brain tumors.
- Experimental validation of 5 in-silico predicted glioma biomarkers.
- Use of quantitative 16S rRNA PCR to determine bacterial load does not augment conventional Cerebrospinal fluid (CSF) cultures among children undergoing treatment for C...
- Differential Scanning Calorimetry of Gliomas: A New Tool in Brain Cancer Diagnostics?
- Erratum to: Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme.
- Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007.
- ELTD1, a potential new biomarker for Gliomas.
- Comparison of 18F-Fluorodeoxyglucose and 18F-Fluorothymidine PET in Differentiating Radiation Necrosis From Recurrent Glioma.
- Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme.
- Image guidance for Brain metastases resection.
- Predicting outcomes of patients with intracranial Meningiomas using molecular markers of hypoxia, vascularity, and proliferation.
- Hypoxia-inducible factor-1-regulated protein expression and oligodendroglioma patient outcome: comparison with established biomarkers and preoperative UCSF low-grade s...
- In vivo characterization of several rodent glioma models by (1) H MRS.
- Preliminary use of differential scanning calorimetry of Cerebrospinal fluid for the diagnosis of glioblastoma multiforme.
- Aberrant signaling pathways in Meningiomas.
- Stereotactic radiosurgery eligibility and selection bias in the treatment of glioblastoma multiforme.
- Overall and progression-free survival and visual and endocrine outcomes for patients with parasellar lesions treated with intensity-modulated stereotactic radiosurgery.
- Pleomorphic liposarcoma originating from intracranial dura mater.
- Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article.
- The role of intra-Cerebrospinal fluid treatment and prophylaxis in patients with solid tumors.
- Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.
- Conformity of LINAC-based stereotactic radiosurgery using dynamic conformal arcs and micro-multileaf collimator.
- Silencing of HIF-1alpha by RNA interference in human glioma cells in vitro and in vivo.
- Multidisciplinary treatment of Brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery.
- A comparison of the cell lines used in meningioma research.
- Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme.
- Novalis intensity-modulated radiosurgery: methods for pretreatment planning.
- A novel model of intracranial meningioma in mice using luciferase-expressing meningioma cells. Laboratory investigation.
- Outcomes of patients with Brain metastases from melanoma and renal cell carcinoma after primary stereotactic radiosurgery.
- Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed Brain metastases.
- Multimodality treatment of melanoma Brain metastases incorporating stereotactic radiosurgery (SRS).
- Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo.
- Transient postictal MRI changes in patients with Brain tumors may mimic disease progression.
- Celecoxib inhibits meningioma tumor growth in a mouse xenograft model.
- Chronic suppressive therapy with calcium channel antagonists for refractory Meningiomas.
- Inflammatory response and meningioma tumorigenesis and the effect of cyclooxygenase-2 inhibitors.
- Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro.
- Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms.
- Variations of disseminated choroid Plexus papilloma: 2 case reports and a review of the literature.
- IntraCerebral amyloidoma can mimic high-grade glioma on magnetic resonance imaging and spectroscopy.
- Surgical strategies for recurrent craniofacial Meningiomas.
- Subependymomas: an analysis of clinical and imaging features.
- Epidermal growth factor receptor gene amplification and protein expression in glioblastoma multiforme: prognostic significance and relationship to other prognostic fac...
- Hypoxia in the tumorigenesis of Gliomas and as a potential target for therapeutic measures.
- Molecular genetics of Meningiomas.
- Ubiquitous expression of cyclooxygenase-2 in Meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic a...
- Role of stereotactic radiosurgery in the treatment of Brain metastases.
- Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients.
- Dose fractionation in stereotactic radiotherapy for parasellar Meningiomas: radiobiological considerations of efficacy and optic nerve tolerance.
- Cauda equina syndrome as a postoperative complication of lumbar Spine surgery.
- Surgical considerations regarding giant dilations of the perivascular spaces.
- Oligodendroglioma and juvenile pilocytic astrocytoma presenting as synchronous primary Brain tumors. Case report with histological and molecular differentiation of the...
- Endolymphatic sac tumors in patients with and without von Hippel-Lindau Disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-...
- Meningioma of the jugular foramen: glomus jugulare mimic and surgical challenge.
- Hypophysial transposition (hypophysopexy) for radiosurgical treatment of pituitary Tumors involving the cavernous sinus. Technical note.
- New approaches for the treatment of refractory Meningiomas.
- Expression of hypoxia inducible factor-1 alpha and correlation with preoperative embolization of Meningiomas.
- Bevacizumab is Effective for Recurrent Papillary Tumor of the Pineal Region: First Report.
- Treatment-related Brain tumor imaging changes: So-called "pseudoprogression" vs. tumor progression: Review and future research opportunities.
Schools
University of Utah
Loyola University Chicago
Procedures Preformed
- Cerebrospinal Fluid (CSF) Shunt - Insertion, Repair or Removal
- Craniectomy, Craniotomy, Surgery of Skull Base, Neuroendoscopy
- Dural Repair or Other Spinal Spinal Cord Repair
- Lamina Procedures (incl. Laminectomy, Laminoplasty, Laminotomy)
- View All
Conditions Treated
- Acoustic Neuroma
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Aneurysm
- Brain Cancer
- View All
Doctors Specialties
- Neurosurgery
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
- Fellow (FAANS)
Education
-
Loyola University -
University of Utah School of Medicine
Hospital
-
University of Utah Health Care - Hospital and Clinics -
Intermountain Medical Center
Drug Facts
| NPI NUMBER | 1982794582 | |
| NPPES Provider LastName | JENSEN | |
| NPPES Provider FirstName | RANDY | |
| NPPES Provider ZIPCode | 841320001 | |
| NPPES Provider State | UT | |
| Specialty Description | Neurosurgery | |
| Total Claim Count | 88.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1982794582 |
| Last Name Of The Provider | JENSEN |
| First Name Of The Provider | RANDY |
| View All |
Similar Doctors
|
|
Dr. Lynn M. Kerr, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marion L. Walker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew T. Dailey, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Douglas L. Brockmeyer, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Daniel W. Fults III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philipp Taussky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pablo Andres Rodriguez Covili, MD |
|
|
Dr. Christina M. Sayama, MD
This Doctor is OpenDoctor Recommended.
|